ArticleOncotarget2018
MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1.
Hui Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleOncotarget2018
Hui Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.